Lyophilised · batch-documented · discreet packaging
CJC
Drug Affinity Complex GHRH Analogue // CAS 863288-34-0 // Sustained GH Release
Long-acting GHRH with albumin-binding DAC modification. Once-weekly dosing for sustained GH and IGF-1 elevation.
CJC-1295 with DAC is a modified growth hormone-releasing hormone analogue conjugated with a Drug Affinity Complex (DAC) that binds reversibly to serum albumin. This modification dramatically extends the half-life from minutes (native GHRH) to approximately 6–8 days, enabling once-weekly dosing while maintaining continuously elevated GH and IGF-1 levels. Unlike pulsatile GHRH peptides such as Sermorelin or CJC-1295 no DAC, this compound creates a sustained baseline of GH stimulation rather than short bursts.
Third-party tested
Every batch independently verified by Janoshik & Freedom Diagnostics for purity and identity.
Full COA included
Certificate of Analysis confirms peptide purity, amino acid composition, and absence of contaminants.
Discreet shipping
Every order ships in plain, unmarked packaging with full tracking. No external branding or product details visible.
Research-grade
Uniform vial presentation, consistent labeling, and batch-level documentation every time.
- Janoshik & Freedom Diagnostics verified
- Certificate of analysis per batch
- Direct-from-manufacturer sourcing
- Discreet, unmarked packaging